Clarisse Nobre, Ph.D. in Chemical and Biological Engineering from the University of Minho in 2011, is an Assistant Researcher and Invited Assistant Professor at the Centre of Biological Engineering at the University of Minho, Portugal.
She has been extensively dedicated to the development of innovative functional foods, mostly prebiotics, having collaborated in 15 inter(national) projects, and having published more than 100 scientific contributions in the area. She has supervised over 30 international students, including Ph.D., and post-doc researchers. She collaborated with the University of Mons, Belgium, for 7 years in the development of integrated processes for prebiotic production and purification. She designed, built, and is currently validating a novel dynamic in vitro colon simulator, allowing microbiota–host interaction, the ColOsH, as principal investigator. Her current research interests are focused on the development of novel multi-organ platforms envisaging the study of the microbiota–gut–brain axis, and its modulation through targeted dietary intervention. (May 2023)
Clarisse Nobre, Ph.D. in Chemical and Biological Engineering from the University of Minho in 2011, is an Assistant Researcher and Invited Assistant Professor at the Centre of Biological Engineering at the University of Minho, Portugal.
She has been extensively dedicated to the development of innovative functional foods, mostly prebiotics, having collaborated in 15 inter(national) projects, and having published more than 100 scientific contributions in the area. She has supervised over 30 international students, including Ph.D., and post-doc researchers. She collaborated with the University of Mons, Belgium, for 7 years in the development of integrated processes for prebiotic production and purification. She designed, built, and is currently validating a novel dynamic in vitro colon simulator, allowing microbiota–host interaction, the ColOsH, as principal investigator. Her current research interests are focused on the development of novel multi-organ platforms envisaging the study of the microbiota–gut–brain axis, and its modulation through targeted dietary intervention. (May 2023)